BHC
MaterialsBausch Health Companies Inc
$5.65+0.01 (+0.18%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving BHC Today?
No stock-specific AI insight has been generated for BHC yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$2.1B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding373.5M
BHC News
22 articles- Why Bausch Health Companies Was Crawling Higher This WeekThe Motley Fool·May 1, 2026
- TSX up 455 Points at Midday With Healthcare, Materials, The Best PerformersYahoo Finance·Apr 30, 2026
- BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta StrengthYahoo Finance·Apr 30, 2026
- Bausch Health Companies Inc. Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Apr 30, 2026
- Bausch + Lomb Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health Cos Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health (BHC) Lags Q1 Earnings EstimatesYahoo Finance·Apr 30, 2026
- Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key MetricsYahoo Finance·Apr 30, 2026
- Bausch Health (BHC) Q1 2026 Earnings TranscriptMotley Fool·Apr 29, 2026
- Bausch Health Q1 Adjusted Earnings, Revenue, Advance, Beating EstimatesYahoo Finance·Apr 29, 2026
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTSYahoo Finance·Apr 29, 2026
- Bausch Health's Q1 Total Prescriptions Hurt by Exit From Federal Drug Pricing Programs, RBC SaysYahoo Finance·Apr 27, 2026
- Bausch Health Companies Inc. (BHC): Billionaire Howard Marks Likes This Pharma StockYahoo Finance·Apr 27, 2026
- Bausch Health (BHC) Q3 2024 Earnings TranscriptMotley Fool·Apr 22, 2026
- Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | DelveInsightGlobeNewswire Inc.·Apr 20, 2026
- Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online OrderingYahoo Finance·Apr 14, 2026
- Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic DemandGlobeNewswire Inc.·Apr 13, 2026
- What Makes Bausch Health (BHC) Appear So AttractiveYahoo Finance·Mar 31, 2026
- Bausch Health to Announce First Quarter 2026 Results on April 29, 2026Yahoo Finance·Mar 31, 2026
- Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship ProgramYahoo Finance·Mar 26, 2026
- Is the Options Market Predicting a Spike in Bausch Health Stock?Yahoo Finance·Mar 24, 2026
All 22 articles loaded
Price Data
Open$5.69
Previous Close$5.64
Day High$5.72
Day Low$5.60
52 Week High—
52 Week Low—
Fundamentals
Market Cap$2.1B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding373.5M
About Bausch Health Companies Inc
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
MaterialsPHARMACEUTICAL PREPARATIONS
Company Details
Security TypeStock
ExchangeNYSE
Currency—
Round Lot—
SICPHARMACEUTICAL PREPARATIONS
CIK—
Composite FIGI—
Share Class FIGI—